PART I. FINANCIAL
INFORMATION
Item 1. Financial Statements
First Consulting Group, Inc. and Subsidiaries
Consolidated Balance Sheets
(in thousands, except share and per share data)
(unaudited)
|
|
September 28,
|
|
December 29,
|
|
|
|
2007
|
|
2006
|
|
ASSETS
|
|
|
|
|
|
Current
assets:
|
|
|
|
|
|
Cash and
cash equivalents
|
|
$
|
85,932
|
|
$
|
58,493
|
|
Short-term
investments
|
|
10,000
|
|
5,004
|
|
Accounts
receivable, less allowance of $1,285 and $1,648 as of September 28, 2007 and
December 29, 2006, respectively
|
|
17,362
|
|
20,485
|
|
Unbilled
receivables
|
|
17,807
|
|
12,124
|
|
Prepaid
expenses and other current assets
|
|
4,289
|
|
3,957
|
|
Current
assets of discontinued operations
|
|
1,871
|
|
216
|
|
Total
current assets
|
|
137,261
|
|
100,279
|
|
|
|
|
|
|
|
Property and
equipment:
|
|
|
|
|
|
Furniture,
equipment, and leasehold improvements
|
|
7,617
|
|
6,905
|
|
Information
systems equipment and software
|
|
28,329
|
|
29,608
|
|
|
|
35,946
|
|
36,513
|
|
Less
accumulated depreciation and amortization
|
|
26,965
|
|
25,516
|
|
|
|
8,981
|
|
10,997
|
|
|
|
|
|
|
|
Other
assets:
|
|
|
|
|
|
Executive
benefit trust
|
|
11,961
|
|
11,079
|
|
Long-term
accounts receivable, net
|
|
2,339
|
|
2,413
|
|
Long-term
investments
|
|
2,758
|
|
325
|
|
Deferred
contract costs
|
|
8,733
|
|
5,255
|
|
Deferred
income taxes
|
|
6,316
|
|
|
|
Goodwill,
net
|
|
18,042
|
|
17,820
|
|
Intangibles,
net
|
|
170
|
|
456
|
|
Other
|
|
1,705
|
|
2,437
|
|
Non-current
assets of discontinued operations
|
|
|
|
432
|
|
|
|
52,024
|
|
40,217
|
|
Total assets
|
|
$
|
198,266
|
|
$
|
151,493
|
|
The accompanying notes are an integral part
of these consolidated financial statements.
3
First Consulting Group, Inc. and Subsidiaries
Consolidated Balance Sheets (Continued)
(in thousands, except share and per share data)
(unaudited)
|
|
September 28,
|
|
December 29,
|
|
|
|
2007
|
|
2006
|
|
LIABILITIES
AND STOCKHOLDERS EQUITY
|
|
|
|
|
|
Current
liabilities:
|
|
|
|
|
|
Accounts
payable
|
|
$
|
2,583
|
|
$
|
2,381
|
|
Accrued
liabilities
|
|
3,097
|
|
2,377
|
|
Accrued
payroll and payroll taxes
|
|
3,974
|
|
2,694
|
|
Accrued
vacation
|
|
6,237
|
|
5,879
|
|
Accrued
employee benefits
|
|
3,038
|
|
2,108
|
|
Accrued
incentive compensation
|
|
3,272
|
|
937
|
|
Customer
advances
|
|
11,025
|
|
10,086
|
|
Taxes
payable
|
|
12,143
|
|
1,630
|
|
Current
liabilities of discontinued operations
|
|
251
|
|
1,866
|
|
Total
current liabilities
|
|
45,620
|
|
29,958
|
|
Non-current
liabilities:
|
|
|
|
|
|
Supplemental
executive retirement plan
|
|
8,601
|
|
10,193
|
|
|
|
|
|
|
|
Commitments
and contingencies
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders
equity:
|
|
|
|
|
|
Preferred
Stock, $.001 par value; 9,500,000 shares authorized, no shares issued and
outstanding
|
|
|
|
|
|
Series A
Junior Participating Preferred Stock, $.001 par value; 500,000 shares
authorized, no shares issued and outstanding
|
|
|
|
|
|
Common
Stock, $.001 par value; 50,000,000 shares authorized, 27,149,109 shares
issued and outstanding at September 28, 2007 and 26,253,061 shares issued and
outstanding at December 29, 2006
|
|
27
|
|
26
|
|
Additional
paid-in capital
|
|
107,887
|
|
102,739
|
|
Retained
earnings
|
|
35,360
|
|
8,302
|
|
Accumulated
other comprehensive income
|
|
771
|
|
275
|
|
Total
stockholders equity
|
|
144,045
|
|
111,342
|
|
Total
liabilities and stockholders equity
|
|
$
|
198,266
|
|
$
|
151,493
|
|
The accompanying notes are an integral part
of these consolidated financial statements.
4
First Consulting Group, Inc. and Subsidiaries
Consolidated Statements of Operations
(in thousands, except per share data)
(unaudited)
|
|
Three Months Ended
|
|
Nine Months Ended
|
|
|
|
September
28, 2007
|
|
September
29, 2006
|
|
September
28, 2007
|
|
September
29, 2006
|
|
Revenues
before reimbursements
|
|
$
|
66,820
|
|
$
|
64,766
|
|
$
|
200,019
|
|
$
|
195,233
|
|
Reimbursements
|
|
3,817
|
|
3,318
|
|
10,656
|
|
10,557
|
|
Total
revenues
|
|
70,637
|
|
68,084
|
|
210,675
|
|
205,790
|
|
|
|
|
|
|
|
|
|
|
|
Cost of
services before reimbursable expenses
|
|
47,778
|
|
46,406
|
|
145,325
|
|
140,603
|
|
Reimbursable
expenses
|
|
3,817
|
|
3,318
|
|
10,656
|
|
10,557
|
|
Total cost
of services
|
|
51,595
|
|
49,724
|
|
155,981
|
|
151,160
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit
|
|
19,042
|
|
18,360
|
|
54,694
|
|
54,630
|
|
|
|
|
|
|
|
|
|
|
|
Selling
expenses
|
|
3,813
|
|
3,938
|
|
11,746
|
|
12,119
|
|
General and
administrative expenses
|
|
10,232
|
|
8,775
|
|
29,453
|
|
26,862
|
|
Income from
operations
|
|
4,997
|
|
5,647
|
|
13,495
|
|
15,649
|
|
Other income
(expense):
|
|
|
|
|
|
|
|
|
|
Interest
income, net
|
|
976
|
|
646
|
|
2,770
|
|
1,409
|
|
Other income
(expense), net
|
|
22
|
|
(38
|
)
|
11
|
|
(51
|
)
|
Income from
continuing operations before income tax provision (benefit)
|
|
5,995
|
|
6,255
|
|
16,276
|
|
17,007
|
|
Income tax
provision (benefit)
|
|
(4,562
|
)
|
454
|
|
(1,759
|
)
|
1,188
|
|
Income from
continuing operations
|
|
10,557
|
|
5,801
|
|
18,035
|
|
15,819
|
|
Income
(loss) on discontinued operations, net of tax
|
|
10,024
|
|
288
|
|
9,375
|
|
(47
|
)
|
Net income
|
|
$
|
20,581
|
|
$
|
6,089
|
|
$
|
27,410
|
|
$
|
15,772
|
|
|
|
|
|
|
|
|
|
|
|
Basic net
income per share:
|
|
|
|
|
|
|
|
|
|
Income from
continuing operations
|
|
$
|
0.39
|
|
$
|
0.23
|
|
$
|
0.67
|
|
$
|
0.63
|
|
Income on
discontinued operations, net of tax
|
|
0.37
|
|
0.01
|
|
0.35
|
|
|
|
Net income
per share
|
|
$
|
0.76
|
|
$
|
0.24
|
|
$
|
1.02
|
|
$
|
0.63
|
|
|
|
|
|
|
|
|
|
|
|
Diluted net
income per share:
|
|
|
|
|
|
|
|
|
|
Income from
continuing operations
|
|
$
|
0.38
|
|
$
|
0.22
|
|
$
|
0.66
|
|
$
|
0.62
|
|
Income on discontinued
operations, net of tax
|
|
0.37
|
|
0.01
|
|
0.34
|
|
|
|
Net income
per share
|
|
$
|
0.75
|
|
$
|
0.23
|
|
$
|
1.00
|
|
$
|
0.62
|
|
|
|
|
|
|
|
|
|
|
|
Weighted
average shares used in computing:
|
|
|
|
|
|
|
|
|
|
Basic net
income per share
|
|
27,108
|
|
25,472
|
|
26,848
|
|
25,074
|
|
Diluted net
income per share
|
|
27,495
|
|
26,229
|
|
27,461
|
|
25,643
|
|
The accompanying notes are an integral part
of these consolidated financial statements.
5
First Consulting Group, Inc. and Subsidiaries
Consolidated Statements of Cash Flows
(in thousands)
(unaudited)
|
|
Nine Months Ended
|
|
|
|
September 28,
2007
|
|
September 29,
2006
|
|
Cash flows
from operating activities:
|
|
|
|
|
|
Net income
|
|
$
|
27,410
|
|
$
|
15,772
|
|
Adjustments
to reconcile net income to net cash provided by operating activities:
|
|
|
|
|
|
Depreciation
and amortization
|
|
4,488
|
|
5,330
|
|
Intangible
amortization
|
|
466
|
|
579
|
|
Provision
for bad debts
|
|
(363
|
)
|
(99
|
)
|
Benefit for
deferred income taxes
|
|
(6,316
|
)
|
|
|
Loss on
sale/disposal of assets
|
|
250
|
|
473
|
|
Stock-based
compensation
|
|
1,003
|
|
629
|
|
In-process
research and development expenses acquired
|
|
1,580
|
|
|
|
(Gain) loss
on operations of discontinued operations, net of tax
|
|
(9,375
|
)
|
47
|
|
Change in
assets and liabilities:
|
|
|
|
|
|
Accounts receivable
|
|
3,486
|
|
3,111
|
|
Unbilled
receivables
|
|
(5,683
|
)
|
(2,869
|
)
|
Prepaid
expenses and other current assets
|
|
(318
|
)
|
60
|
|
Long-term
accounts receivable
|
|
74
|
|
(710
|
)
|
Deferred
contract costs
|
|
(3,478
|
)
|
(1,102
|
)
|
Other assets
|
|
610
|
|
(397
|
)
|
Accounts
payable
|
|
202
|
|
317
|
|
Accrued
liabilities
|
|
720
|
|
(1,951
|
)
|
Accrued
payroll and payroll taxes
|
|
1,280
|
|
(564
|
)
|
Accrued
vacation
|
|
358
|
|
(999
|
)
|
Accrued
employee benefits
|
|
930
|
|
158
|
|
Accrued
incentive compensation
|
|
2,335
|
|
761
|
|
Customer
advances
|
|
939
|
|
178
|
|
Accrued
restructuring costs
|
|
|
|
(2,545
|
)
|
Taxes
payable
|
|
4,410
|
|
657
|
|
Supplemental
executive retirement plan
|
|
(2,474
|
)
|
(740
|
)
|
Other
|
|
(128
|
)
|
(97
|
)
|
Net cash
provided by operating activities of continuing operations
|
|
22,406
|
|
15,999
|
|
Net cash
provided by (used in) operating activities of discontinued operations
|
|
(1,418
|
)
|
1,717
|
|
Net cash
provided by operating activities
|
|
20,988
|
|
17,716
|
|
Cash flows
from investing activities:
|
|
|
|
|
|
Purchase of
investments, net
|
|
(7,429
|
)
|
(3,009
|
)
|
Purchase of
property and equipment
|
|
(2,519
|
)
|
(4,358
|
)
|
Acquisition
of business, net of cash
|
|
(2,061
|
)
|
|
|
Net cash
used in investing activities of continuing operations
|
|
(12,009
|
)
|
(7,367
|
)
|
Net cash
provided by investing activities of discontinued operations
|
|
13,762
|
|
|
|
Net cash
provided by (used in) investing activities
|
|
1,753
|
|
(7,367
|
)
|
Cash flows
from financing activities:
|
|
|
|
|
|
Proceeds
from issuance of capital stock, net
|
|
4,166
|
|
5,465
|
|
Collections
of loan receivable
|
|
102
|
|
61
|
|
Net cash
provided by financing activities
|
|
4,268
|
|
5,526
|
|
Effect of
exchange rate changes on cash and cash equivalents
|
|
430
|
|
215
|
|
Net change
in cash and cash equivalents
|
|
27,439
|
|
16,090
|
|
Cash and
cash equivalents at beginning of period
|
|
58,493
|
|
35,106
|
|
Cash and
cash equivalents at end of period
|
|
$
|
85,932
|
|
$
|
51,196
|
|
|
|
|
|
|
|
Supplemental
disclosure of cash flow information
|
|
|
|
|
|
Cash paid
during the period for interest
|
|
$
|
2
|
|
$
|
5
|
|
Cash paid
during the period for income taxes, net of refunds
|
|
$
|
220
|
|
$
|
530
|
|
The accompanying notes are an integral part
of these consolidated financial statements.
6
First Consulting Group, Inc. and Subsidiaries
Notes to
Consolidated Financial Statements
September 28, 2007
Note 1
Accounting Policies
Basis of Presentation
The accompanying
consolidated balance sheet of First Consulting Group, Inc. and subsidiaries (the
Company or FCG) at September 28, 2007 and consolidated statements of
operations and consolidated statements of cash flows for the three-month and
nine-month periods ended September 28, 2007 and September 29, 2006 are
unaudited. These interim financial statements reflect all adjustments,
consisting of only normal recurring adjustments, which, in the opinion of
management, are necessary to fairly present the financial position of the
Company at September 28, 2007 and the results of operations for the three-month
and nine-month periods ended September 28, 2007 and September 29, 2006. The
results of operations and cash flows for the three-month and nine-month period
ended September 28, 2007 are not necessarily indicative of the results to be
expected for the year ending December 28, 2007. For more complete financial
information, these financial statements should be read in conjunction with the
audited financial statements for the year ended December 29, 2006 included in
the Companys Annual Report on Form 10-K.
Principles of Consolidation
The
consolidated financial statements include the accounts of the Company and its
wholly owned subsidiaries. All material intercompany accounts and transactions
have been eliminated. The Company operates on a fiscal year consisting of a 52
or 53 week period ending on the last Friday in December.
Stock-Based Compensation
Restricted Stock
A summary of restricted
stock activity for the nine months ended September 28, 2007 is as follows:
|
|
Shares
|
|
Weighted Average
Grant Date
Fair Value
|
|
Balance at
December 29, 2006
|
|
130,000
|
|
$
|
8.49
|
|
Grants
|
|
290,800
|
|
12.87
|
|
Cancelled
|
|
(109,900
|
)
|
11.30
|
|
Balance at
September 28, 2007
|
|
310,900
|
|
11.59
|
|
|
|
|
|
|
|
|
During the
nine months ended September 28, 2007, the Company issued 290,800 shares of
restricted stock awards with a vesting period of three and four years to eight
board members and 50 vice presidents, respectively. For the three months ended
September 28, 2007, the Company recognized $4,000 of compensation costs related
to these awards of which an expense reversal of $56,000 was a component of cost
of services, an expense of $2,000 was a component of selling expense, and an
expense of $58,000 was a component of general and administrative expense. For
the nine months ended September 28, 2007, the Company recognized $410,000 of
compensation costs related to these awards of which $140,000 was a component of
cost of services, $37,000 was a component of selling expense, and
7
$233,000 was a component of general and
administrative expense. At September 28, 2007, there was $3.1 million of total
unrecognized compensation costs related to unvested stock, which is expected to
be recognized over a weighted average period of 3.4 years. During the third
quarter of 2007, the Company re-evaluated the estimated forfeiture rate on its
2007 awards. The impact of this adjustment was a reduction in expense of
$104,000.
In August
2006, the Company issued 180,000 shares of restricted stock awards with a
vesting period of five years to seven vice presidents and recognized $51,000 of
compensation costs during the three and nine months ended September 29, 2006.
Accounting for Stock Options
The Company
follows the provisions of SFAS 123 (revised 2004),
Share-Based
Payment (SFAS 123R) using the modified prospective transition method.
Upon adoption of SFAS 123R, the Company changed its method of attributing the
value of stock option-based compensation expense from the multiple-option
(i.e., accelerated) approach to the single-option (i.e., straight-line) method.
Compensation expense for share-based awards granted through December 30,
2005 continues to be subject to the accelerated multiple-option method, while
compensation expense for share-based awards granted on or after
December 31, 2005 is recognized using a straight-line, or single-option
method. The Company recognizes these compensation costs over the service period
of the award, which is generally the option vesting term of three to four
years.
SFAS 123R
requires forfeitures to be estimated at the time of grant and revised, if
necessary, in subsequent periods if actual forfeitures differ from those
estimates in order to derive the Companys best estimate of awards ultimately
expected to vest. Forfeitures have been estimated based on the Companys
historical experience.
Valuation and Expense Information under SFAS
123R
Expense
associated with stock option-based compensation for the three and nine months
ended September 28, 2007 is $186,000 and $593,000, respectively, which had the
effect of reducing operating income and net income by this amount, and reducing
basic and diluted earnings per share by less than $0.01 for the three-month
period and $0.02 for the nine-month period. For the three and nine months ended
September 29, 2006, the stock option-based compensation was $230,000 and
$578,000, respectively, which had the effect of reducing basic and diluted
earnings per share by $0.01 for the three-month period and $0.02 for the
nine-month period.
The following represents the
cost classification of the stock option-based compensation for the three and
nine months ended September 28, 2007 and September 29, 2006 (in thousands):
|
|
Three Months Ended
|
|
Nine months Ended
|
|
|
|
September
28, 2007
|
|
September
29, 2006
|
|
September
28, 2007
|
|
September
29, 2006
|
|
Cost of
services
|
|
$
|
19
|
|
$
|
50
|
|
$
|
72
|
|
$
|
187
|
|
Selling
|
|
7
|
|
30
|
|
24
|
|
97
|
|
General and
administrative
|
|
160
|
|
150
|
|
497
|
|
294
|
|
Total stock
option-based compensation
|
|
$
|
186
|
|
$
|
230
|
|
$
|
593
|
|
$
|
578
|
|
Tax benefits
resulting from tax deductions in excess of the compensation cost recognized for
those options are classified as financing cash flows. For the nine months ended
September 28, 2007, the Company recognized $60,000 of tax benefit related to
stock option-based compensation. For the nine months ended September 29, 2006,
the Company did not recognize any tax benefit related to stock
8
option-based compensation expense because the
Company maintained a full valuation allowance on its deferred tax assets at the
time.
The Company
uses the Black-Scholes option pricing model to value its options. There were no
options granted during the nine months ended September 28, 2007. The fair value
of the options granted during the nine months ended September 29, 2006
calculated using the Black-Scholes pricing model was $4.30 per share. The
following assumptions were used in the Black-Scholes pricing model:
|
|
Three Months Ended
|
|
Nine months Ended
|
|
|
|
September 29, 2006
|
|
September 29, 2006
|
|
Dividend
yield
|
|
|
|
-
|
|
Expected
volatility
|
|
|
|
0.46 - 0.59
|
|
Weighted
average expected volatility
|
|
|
|
0.47
|
|
Risk-free
interest rate
|
|
|
|
4.28% - 5.02%
|
|
Expected
life
|
|
|
|
5 to 6 years
|
|
Expected
volatilities are based on the Companys historical volatility of its common
shares over a period of time equal to the expected term of the stock option.
The risk-free interest rate assumption is based upon observed interest rates
appropriate for the term of the stock option. The expected dividend yield is
zero as the Company does not expect to pay dividends in the future.
Stock option
activity for the nine months ended September 28, 2007 is as follows:
|
|
Shares
|
|
Weighted Average
Exercise Price
|
|
Weighted Average
Remaining
Contractual Life
(Years)
|
|
Aggregate
Intrinsic
Value
|
|
Outstanding
at December 29, 2006
|
|
2,915,960
|
|
$
|
7.73
|
|
|
|
|
|
Exercised
|
|
(717,438
|
)
|
$
|
5.81
|
|
|
|
|
|
Cancelled
|
|
(167,569
|
)
|
$
|
10.03
|
|
|
|
|
|
Outstanding
at September 28, 2007
|
|
2,030,953
|
|
$
|
8.21
|
|
5.30
|
|
$
|
5,344,688
|
|
|
|
|
|
|
|
|
|
|
|
Exercisable
at September 28, 2007
|
|
1,583,120
|
|
$
|
8.17
|
|
4.46
|
|
$
|
4,481,688
|
|
The aggregate
intrinsic value in the table above represents the total pre-tax intrinsic
value, based on the Companys closing stock price of $10.30 on September 28,
2007, which would have been received by the option holders had all option
holders exercised their options on September 28, 2007. This amount changes
based on the fair market value of the Companys stock. Total intrinsic value of
options exercised for the nine months ended September 28, 2007 and September
29, 2006 were $3.2 million and $1.9 million, respectively. As of September 28, 2007, there was $1.6
million of total unrecognized compensation cost related to unvested stock
options. This cost is expected to be recognized over a weighted average period
of approximately 2.3 years.
Basic and Diluted Net Income per Share
Basic net
income per share is computed using the weighted average number of common shares
outstanding. Diluted net income per share is computed using the assumption that
stock options were exercised. Dilution is computed by applying the treasury
stock method. Under this method, options are assumed to be exercised at the
beginning of the period (or at the time of issuance, if later), and as if funds
obtained by the Company from such exercise were used by the Company to purchase
common stock at the average market price during the period.
9
The following represents a
reconciliation of basic and diluted net income per share for the three and nine
months ended September 28, 2007 and September 29, 2006 (in thousands, except
per share data):
|
|
Three Months Ended
|
|
Nine months Ended
|
|
|
|
September
28, 2007
|
|
September
29, 2006
|
|
September
28, 2007
|
|
September
29, 2006
|
|
Income
(loss) from continuing operations
|
|
$
|
10,557
|
|
$
|
5,801
|
|
$
|
18,035
|
|
$
|
15,819
|
|
Gain (loss)
on discontinued operations, net of tax
|
|
10,024
|
|
288
|
|
9,375
|
|
(47
|
)
|
Net income
|
|
$
|
20,581
|
|
$
|
6,089
|
|
$
|
27,410
|
|
$
|
15,772
|
|
|
|
|
|
|
|
|
|
|
|
Basic
weighted average number of shares outstanding
|
|
27,108
|
|
25,472
|
|
26,848
|
|
25,074
|
|
Effect of
dilutive options and contingent shares
|
|
387
|
|
757
|
|
613
|
|
569
|
|
Diluted
weighted average number of shares outstanding
|
|
27,495
|
|
26,229
|
|
27,461
|
|
25,643
|
|
|
|
|
|
|
|
|
|
|
|
Basic net
income per share:
|
|
|
|
|
|
|
|
|
|
Income from
continuing operations
|
|
$
|
0.39
|
|
$
|
0.23
|
|
$
|
0.67
|
|
$
|
0.63
|
|
Income on
discontinued operations, net of tax
|
|
0.37
|
|
0.01
|
|
0.35
|
|
|
|
Net income
per share
|
|
$
|
0.76
|
|
$
|
0.24
|
|
$
|
1.02
|
|
$
|
0.63
|
|
|
|
|
|
|
|
|
|
|
|
Diluted net
income per share:
|
|
|
|
|
|
|
|
|
|
Income from
continuing operations
|
|
$
|
0.38
|
|
$
|
0.22
|
|
$
|
0.66
|
|
$
|
0.62
|
|
Income on
discontinued operations, net of tax
|
|
0.37
|
|
0.01
|
|
0.34
|
|
|
|
Net income
per share
|
|
$
|
0.75
|
|
$
|
0.23
|
|
$
|
1.00
|
|
$
|
0.62
|
|
For the three months ended
September 28, 2007 and September 29, 2006, there were 856,635 and 1,288,392
anti-dilutive outstanding stock options, respectively, excluded from the
calculation of diluted income per share. For the nine months ended September
28, 2007 and September 29, 2006, there were 809,932 and 2,003,147 anti-dilutive
outstanding stock options, respectively, excluded from the calculation of
diluted income per share.
Use of Estimates
In preparing
financial statements in conformity with accounting principles generally
accepted in the United States of America, management is required to make
estimates and assumptions that affect the reported amounts of assets and
liabilities, the disclosure of contingent assets and liabilities at the date of
the financial statements, and the reported amounts of revenues and expenses
during the reporting period. Actual results could differ from those estimates. On
an ongoing basis, management evaluates its estimates, including those related
to revenue recognition, valuation of goodwill, stock-based compensation,
long-lived and intangible assets, accrued liabilities, income taxes including
the amount of tax asset valuation allowance required, facility closure costs,
litigation and disputes, and the allowance for doubtful accounts.
Management
bases its estimates on historical experience and on various other assumptions
that are believed to be reasonable under the circumstances, the results of
which form the basis for making judgments about the carrying values of assets
and liabilities that are not readily apparent from other sources. Such
estimates are subject to a number of assumptions, risks, and uncertainties,
many of which are beyond the Companys control. The Companys actual results
may differ from its estimates.
10
Cash and Cash Equivalents
For purposes
of reporting, cash and cash equivalents include cash and interest-earning
deposits or securities purchased with original maturities of three months or
less.
Recent
Accounting Pronouncements
Fair Value Measurements
In
September 2006 and February 2007, respectively, the FASB issued SFAS 157, Fair
Value Measurements (SFAS 157), which provides guidance for using fair value
to measure assets and liabilities, and SFAS 159, The Fair
Value Option for Financial Assets and Financial Liabilities (SFAS 159),
which allows the measurement of many financial instruments and certain other
items at fair value. SFAS 157 will apply whenever another standard requires
or permits assets or liabilities to be measured at fair value. The standard
does not expand the use of fair value to any new circumstances. SFAS 159 will
permit companies to use fair value measurements in certain circumstances. Both
standards are effective for financial statements issued for fiscal years
beginning after November 15, 2007. The Company is currently evaluating the
impact of SFAS 157 and SFAS 159 on its consolidated financial position and
results of operations.
Accounting for Uncertainty in Income Taxes
In June 2006,
the FASB issued FASB Interpretation 48, Accounting for Uncertainty in Income
Taxes (FIN 48). FIN 48 clarifies the application of SFAS 109, Accounting
for Income Taxes, by establishing a threshold condition that a tax position
must meet for any part of the benefit of that position to be recognized in the
financial statements. In addition to recognition, FIN 48 provides guidance
concerning measurement, de-recognition, classification, and disclosure of tax
positions. FIN 48 is effective for fiscal years beginning after December 15,
2006. The Company adopted FIN 48 in the first quarter of 2007 and recorded a
cumulative effect adjustment of $352,000 which was accounted for as an
adjustment to the beginning balance of retained earnings. See Note 9, Income
Taxes for additional information regarding such adoption.
Note 2
Investments
The Company
had $10.0 million in short-term investments and $2.5 million in long-term
investments at September 28, 2007 and $5.0 million in short-term investments at
December 29, 2006. Such investments were held primarily in corporate notes and
government agency securities. Gross and net unrealized gains and losses on
investments were immaterial at September 28, 2007. Additionally, the Company
had $300,000 and $325,000 of non-marketable equity investments at September 28,
2007 and December 29, 2006, respectively, valued at the lower of cost or
estimated fair value, which were included within long-term investments.
Note 3
Long-Term Accounts Receivable
The Company
had long-term accounts receivable at September 28, 2007 and December 29, 2006
of $2.3 million and $2.4 million. Of the long-term account receivable of $2.3
million at September 28, 2007, $1.3 million was created in August 2005 through
the deferral until 2009 of the first month of fees of a new outsourcing
contract. In January 2006, an additional amount of approximately $800,000
related to this contract was deferred until 2009. Both deferrals were in
accordance with the terms of the contract executed with this client in July
2005. Imputed interest income at a rate of 7.0% of $119,000 was accrued during
the first nine months of 2007 on this receivable. Unamortized discount of
$398,000 remained at September 28, 2007.
11
Note 4
Business Acquisition
On June 15,
2007, the Company acquired 100% of the outstanding common stock of Zorch, Inc.
(Zorch), a Salt Lake City, Utah-based company that has developed a proprietary
enterprise software solution to provide regulated content management and
collaboration for the life sciences industry using the Microsoft Office
SharePoint Server 2007 platform. The Company paid $2.0 million in cash to the
shareholders of Zorch. Additionally, the shareholders may earn up to $2.0
million of additional consideration for the sale if the business achieves
certain revenue targets during the period from acquisition through June 30,
2008, and further consideration if operating income from the acquired business
exceeds 14% of revenues during an earnout period that commences in the second
half of 2008 and ends in the first quarter of 2011. The Company incurred a
one-time charge of approximately $1.6 million during the second quarter of
fiscal year 2007 in recognition of acquired in-process software research and
development expenses.
The following table summarizes the estimated
fair values of assets acquired as of June 15, 2007 in connection with the Zorch
acquisition (in thousands):
Other
current assets
|
|
$
|
14
|
|
Property,
plant, and equipment
|
|
9
|
|
Software
|
|
180
|
|
Goodwill
|
|
278
|
|
In-process
research and development
|
|
1,580
|
|
Cash
consideration
|
|
$
|
2,061
|
|
The results of operations of Zorch have been
included in the accompanying financial statements for the period from June 16,
2007 through September 28, 2007. Pro forma information as if Zorch had been
acquired on January 1, 2006 has not been provided, since such pro forma results
do not differ materially from those reported in the accompanying financial
statements.
Note 5
Goodwill and Intangible Assets
Under SFAS
142, the Company completes an annual impairment testing which is performed
during the fourth quarter of each year. The Company believes that the
accounting assumptions and estimates related to the annual goodwill impairment
testing are critical because these can change from period to period.
Various assumptions, such as discount rates, and comparable company analysis
are used in performing these valuations. The impairment test requires the
Company to forecast future cash flows, which involves significant
judgment. Accordingly, if expectations of future operating results
change, or if there are changes to other assumptions, estimates of the fair
value of reporting units could change significantly resulting in a goodwill
impairment charge, which could have a significant impact on the consolidated
financial statements. The Company performed an impairment test on each of
its components of goodwill as of the fourth quarter of fiscal year 2006 and
determined that none of its goodwill was impaired. As of September 28, 2007,
the Company had $18.0 million of goodwill and $170,000 of amortizable
intangible assets recorded on its balance sheet.
12
The amounts of goodwill at
September 28, 2007 are as follows (in thousands):
|
|
Health
Delivery
Services
|
|
Health
Delivery
Outsourcing
|
|
Life
Sciences
|
|
Software
Services
|
|
Total
|
|
Balance as
of December 29, 2006
|
|
$
|
3,225
|
|
$
|
5,193
|
|
$
|
1,481
|
|
$
|
7,921
|
|
$
|
17,820
|
|
Acquired
|
|
|
|
|
|
278
|
|
|
|
278
|
|
Use of
acquired net operating loss carryforward
|
|
|
|
|
|
|
|
(56
|
)
|
(56
|
)
|
Balance as
of September 28, 2007
|
|
$
|
3,225
|
|
$
|
5,193
|
|
$
|
1,759
|
|
$
|
7,865
|
|
$
|
18,042
|
|
As of September 28, 2007,
the Company had the following acquired intangible assets (in thousands):
|
|
Customer Related
|
|
Software
|
|
Total
|
|
Balance as
of December 29, 2006
|
|
$
|
456
|
|
$
|
|
|
$
|
456
|
|
Acquired
|
|
|
|
180
|
|
180
|
|
Amortization
|
|
(456
|
)
|
(10
|
)
|
(466
|
)
|
Balance as
of September 28, 2007
|
|
$
|
|
|
$
|
170
|
|
$
|
170
|
|
Amortization
Period in Years
|
|
4
|
|
5
|
|
|
|
The following table
summarizes the estimated remaining annual pretax amortization expense for these
assets (in thousands):
Fiscal Year
|
|
|
|
2007
(remainder of year)
|
|
$
|
9
|
|
2008
|
|
36
|
|
2009
|
|
36
|
|
2010
|
|
36
|
|
2011
|
|
36
|
|
2012
|
|
17
|
|
Total
|
|
$
|
170
|
|
Note 6
Comprehensive Income
Comprehensive income, net of
taxes, for the three and nine months ended September 28, 2007 and September 29,
2006, is as follows (in thousands):
|
|
Three Months Ended
|
|
Nine months Ended
|
|
|
|
September
28, 2007
|
|
September
29, 2006
|
|
September
28, 2007
|
|
September
29, 2006
|
|
Net income
|
|
$
|
20,581
|
|
$
|
6,089
|
|
$
|
27,410
|
|
$
|
15,772
|
|
|
|
|
|
|
|
|
|
|
|
Foreign
currency translation adjustment
|
|
212
|
|
40
|
|
493
|
|
50
|
|
Unrealized
gain (loss) on investments
|
|
4
|
|
5
|
|
3
|
|
(7
|
)
|
Other comprehensive
loss, net of tax
|
|
216
|
|
45
|
|
496
|
|
43
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive
income
|
|
$
|
20,797
|
|
$
|
6,134
|
|
$
|
27,906
|
|
$
|
15,815
|
|
The translation gain for the
three and nine months ended September 28, 2007 is due to the weakening of the
U.S. dollar against currencies in European and Asian countries, where the
Company has assets.
13
Note 7
Discontinued Operations
The Company
completed the sale of its Software Products segment on September 12, 2007 and the
disposition has been accounted for as a discontinued operation in accordance
with SFAS 144, Accounting for the Impairment or Disposal of Long-Lived Assets
(SFAS 144). The Company received $13.8
million in cash from the sale, resulting in a pretax gain from the disposition
of discontinued operations of $17.1 million during the third quarter of 2007,
which includes certain software subscription revenue that had been deferred as
a customer advance, net of the related deferred costs. Additionally, the Company may receive up to
$3 million in additional sale proceeds if future revenues of the business
exceed certain targets.
Income from
discontinued operations was $10.0 million (net of $6.2 million of income tax)
or $0.37 per share in the quarter ended September 28, 2007, compared to income
from discontinued operations of $288,000 or $0.01 per share in the quarter
ended September 29, 2006. During the
quarter ended September 28, 2007, the Company incurred an $824,000 operating
loss from this discontinued operation, compared to a $399,000 operating loss
for the quarter ended September 29, 2006.
Income from discontinued operations was $9.4 million (net of $5.8
million of income tax) or $0.35 per share, in the nine months ended September
28, 2007, compared to a loss from discontinued operations of $47,000 or $0.00
per share in the nine months ended September 29, 2006. During the nine months ended September 28,
2007, the Company incurred a $1.9 million operating loss from this discontinued
operation, compared to a $739,000 operating loss for the nine months ended
September 29, 2006. A 38.3% tax rate was
applied to the discontinued operations in fiscal year 2007 compared to a 1.4%
rate in fiscal year 2006. Revenues for
the discontinued operation were $1.0 million and $2.2 million for the nine
months ended September 28, 2007 and September 29, 2006, respectively.
On August 21,
2006, the Company sold its Cyberview software product and related intellectual
property and service contracts to Medisolv, Inc and recognized $691,000 of
pretax other income in the third quarter of fiscal year 2006, which is included
in discontinued operations, since Cyberview was part of the Software Products
segment.
Note 8
Disclosure of Segment Information
For fiscal
year 2007, the Company has the following five reportable segments:
Health
Delivery Services - the delivery of consulting and systems integration services
to health delivery and government clients;
Health
Delivery Outsourcing - the delivery of outsourcing services to health delivery
clients;
Life
Sciences - the sale of enterprise content management software and the delivery
of related consulting and systems integration services to pharmaceutical and
other life sciences clients;
Health
Plans - the delivery of consulting and systems integration services and
outsourcing services to health plan clients;
Software
Services - the delivery of blended shore software development; and
Additionally,
the Company has four shared service centers that provide services to multiple
business segments. These shared service centers include FCG India, FCG Vietnam,
Integration Services, and Infrastructure Services. The costs of these services
are internally billed and reported in the individual business segments as cost
of services at a standard transfer cost.
The Company
evaluates its segments performance based on revenues and operating income. Certain
selling and general and administrative expenses (including corporate functions,
occupancy related costs, depreciation, professional development, recruiting,
and marketing) are managed at the corporate level and allocated to each
operating segment based on either net revenues and/or actual usage. The Company
does not manage or track most assets by segment. As a result, interest and other
charges are not included in the tables below.
14
The following
segment information is for the three months and nine months ended September 28,
2007 and September 29, 2006
(in thousands):
For the three months ended
September 28, 2007:
(in thousands)
|
|
Health
Delivery
Services
|
|
Health
Delivery
Outsourcing
|
|
Life
Sciences
|
|
Health
Plans
|
|
Software
Services
|
|
Other
|
|
Totals
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues before reimbursements
|
|
$
|
15,120
|
|
$
|
27,580
|
|
$
|
8,617
|
|
$
|
9,407
|
|
$
|
6,096
|
|
$
|
|
|
$
|
66,820
|
|
Reimbursements
|
|
2,329
|
|
195
|
|
106
|
|
1,097
|
|
90
|
|
|
|
3,817
|
|
Total revenues
|
|
17,449
|
|
27,775
|
|
8,723
|
|
10,504
|
|
6,186
|
|
|
|
70,637
|
|
Cost of services before reimbursable expenses
|
|
9,692
|
|
23,065
|
|
4,069
|
|
6,259
|
|
4,197
|
|
496
|
|
47,778
|
|
Reimbursable expenses
|
|
2,329
|
|
195
|
|
106
|
|
1,097
|
|
90
|
|
|
|
3,817
|
|
Total cost of services
|
|
12,021
|
|
23,260
|
|
4,175
|
|
7,356
|
|
4,287
|
|
496
|
|
51,595
|
|
Gross profit
|
|
5,428
|
|
4,515
|
|
4,548
|
|
3,148
|
|
1,899
|
|
(496
|
)
|
19,042
|
|
Selling expenses
|
|
1,556
|
|
314
|
|
948
|
|
757
|
|
386
|
|
(148
|
)
|
3,813
|
|
General & administrative expenses
|
|
2,109
|
|
2,066
|
|
2,839
|
|
1,348
|
|
910
|
|
960
|
|
10,232
|
|
Income (loss) from operations
|
|
$
|
1,763
|
|
$
|
2,135
|
|
$
|
761
|
|
$
|
1,043
|
|
$
|
603
|
|
$
|
(1,308
|
)
|
$
|
4,997
|
|
For the three months ended
September 29, 2006:
(in thousands)
|
|
Health
Delivery
Services
|
|
Health
Delivery
Outsourcing
|
|
Life
Sciences
|
|
Health
Plan
|
|
Software
Services
|
|
Other
|
|
Totals
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues before reimbursements
|
|
$
|
14,171
|
|
$
|
26,900
|
|
$
|
8,152
|
|
$
|
8,074
|
|
$
|
7,170
|
|
$
|
299
|
|
$
|
64,766
|
|
Reimbursements
|
|
2,078
|
|
32
|
|
129
|
|
916
|
|
162
|
|
1
|
|
3,318
|
|
Total revenues
|
|
16,249
|
|
26,932
|
|
8,281
|
|
8,990
|
|
7,332
|
|
300
|
|
68,084
|
|
Cost of services before reimbursable expenses
|
|
8,299
|
|
23,307
|
|
4,121
|
|
6,087
|
|
4,579
|
|
13
|
|
46,406
|
|
Reimbursable expenses
|
|
2,078
|
|
32
|
|
129
|
|
916
|
|
162
|
|
1
|
|
3,318
|
|
Total cost of services
|
|
10,377
|
|
23,339
|
|
4,250
|
|
7,003
|
|
4,741
|
|
14
|
|
49,724
|
|
Gross profit
|
|
5,872
|
|
3,593
|
|
4,031
|
|
1,987
|
|
2,591
|
|
286
|
|
18,360
|
|
Selling expenses
|
|
1,642
|
|
283
|
|
990
|
|
562
|
|
501
|
|
(40
|
)
|
3,938
|
|
General & administrative expenses
|
|
2,602
|
|
1,878
|
|
1,815
|
|
994
|
|
886
|
|
600
|
|
8,775
|
|
Income (loss) from operations
|
|
$
|
1,628
|
|
$
|
1,432
|
|
$
|
1,226
|
|
$
|
431
|
|
$
|
1,204
|
|
$
|
(274
|
)
|
$
|
5,647
|
|
15
For the nine months ended
September 28, 2007:
(in thousands)
|
|
Health
Delivery
Services
|
|
Health
Delivery
Outsourcing
|
|
Life
Sciences
|
|
Health
Plans
|
|
Software
Services
|
|
Other
|
|
Totals
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues before reimbursements
|
|
$
|
44,885
|
|
$
|
84,204
|
|
$
|
26,889
|
|
$
|
25,422
|
|
$
|
18,619
|
|
$
|
|
|
$
|
200,019
|
|
Reimbursements
|
|
6,924
|
|
424
|
|
327
|
|
2,655
|
|
326
|
|
|
|
10,656
|
|
Total revenues
|
|
51,809
|
|
84,628
|
|
27,216
|
|
28,077
|
|
18,945
|
|
|
|
210,675
|
|
Cost of services before reimbursable expenses
|
|
28,825
|
|
72,836
|
|
11,724
|
|
17,804
|
|
13,408
|
|
728
|
|
145,325
|
|
Reimbursable expenses
|
|
6,924
|
|
424
|
|
327
|
|
2,655
|
|
326
|
|
|
|
10,656
|
|
Total cost of services
|
|
35,749
|
|
73,260
|
|
12,051
|
|
20,459
|
|
13,734
|
|
728
|
|
155,981
|
|
Gross profit
|
|
16,060
|
|
11,368
|
|
15,165
|
|
7,618
|
|
5,211
|
|
(728
|
)
|
54,694
|
|
Selling expenses
|
|
4,697
|
|
861
|
|
3,012
|
|
1,978
|
|
1,514
|
|
(316
|
)
|
11,746
|
|
General & administrative expenses
|
|
6,190
|
|
6,058
|
|
8,812
|
|
3,525
|
|
2,423
|
|
2,445
|
|
29,453
|
|
Income (loss) from operations
|
|
$
|
5,173
|
|
$
|
4,449
|
|
$
|
3,341
|
|
$
|
2,115
|
|
$
|
1,274
|
|
$
|
(2,857
|
)
|
$
|
13,495
|
|
For the nine months ended
September 29, 2006:
(in thousands)
|
|
Health
Delivery
Services
|
|
Health
Delivery
Outsourcing
|
|
Life
Sciences
|
|
Health
Plan
|
|
Software
Services
|
|
Other
|
|
Totals
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues
before reimbursements
|
|
$
|
45,725
|
|
$
|
81,113
|
|
$
|
24,238
|
|
$
|
22,307
|
|
$
|
20,511
|
|
$
|
1,339
|
|
$
|
195,233
|
|
Reimbursements
|
|
6,720
|
|
101
|
|
528
|
|
2,770
|
|
427
|
|
11
|
|
10,557
|
|
Total
revenues
|
|
52,445
|
|
81,214
|
|
24,766
|
|
25,077
|
|
20,938
|
|
1,350
|
|
205,790
|
|
Cost
of services before reimbursable expenses
|
|
27,722
|
|
70,397
|
|
13,411
|
|
15,940
|
|
12,624
|
|
509
|
|
140,603
|
|
Reimbursable
expenses
|
|
6,720
|
|
101
|
|
528
|
|
2,770
|
|
427
|
|
11
|
|
10,557
|
|
Total
cost of services
|
|
34,442
|
|
70,498
|
|
13,939
|
|
18,710
|
|
13,051
|
|
520
|
|
151,160
|
|
Gross
profit
|
|
18,003
|
|
10,716
|
|
10,827
|
|
6,367
|
|
7,887
|
|
830
|
|
54,630
|
|
Selling
expenses
|
|
5,571
|
|
715
|
|
2,719
|
|
1,599
|
|
1,476
|
|
39
|
|
12,119
|
|
General
& administrative expenses
|
|
7,613
|
|
5,711
|
|
6,052
|
|
3,111
|
|
2,444
|
|
1,931
|
|
26,862
|
|
Income
(loss) from operations
|
|
$
|
4,819
|
|
$
|
4,290
|
|
$
|
2,056
|
|
$
|
1,657
|
|
$
|
3,967
|
|
$
|
(1,140
|
)
|
$
|
15,649
|
|
The other column includes reclassifications related to the charging
out of the shared service centers described above, with the net loss in that
column primarily consisting of under absorption of shared service centers or
support costs into the segments.
16
The Companys Software Products segment, which previously delivered
solutions involving the use of software to health delivery clients, has been
accounted for as a discontinued operation due to the completion of its sale on
September 12, 2007
(see
Note 7 of Notes to Consolidated Financial Statements). Certain corporate
general and administrative expenses previously allocated to the Software
Products business have been included in Other as corporate general and
administrative expenses cannot be allocated to a discontinued operation in
accordance with SFAS 144.
Note 9
Income Taxes
The Company recorded a $4.6
million and $1.8 million tax benefit for the three and nine months ended
September 28, 2007 versus a $454,000 and $1.2 million tax provision for the
three and nine months ended September 29, 2006.
The 7% tax provision for the
nine months ended September 29, 2006 was only for current taxes payable for
U.S. federal alternative minimum tax and certain state and foreign income
taxes, as the net operating loss carryforwards offset most of the federal and
certain state tax liabilities. Since these carryforwards have a full valuation
allowance applied against them, their use reduces the income tax rate.
The
estimated tax rate in fiscal year 2007 of
28% on continuing operations has increased significantly from the rate
experienced in fiscal year 2006 as the Company has exhausted its remaining tax
loss carryforwards over the course of this year. Management expects that its
tax provision in 2008 and thereafter will return to levels consistent with
statutory federal and state tax rates.
The valuation allowance for deferred income
taxes has been a particularly volatile estimate over the past four years, as
the Companys level of income and loss has fluctuated, requiring the Company to
reassess the likelihood of realization of the tax assets. Due to cumulative
losses the Company had incurred over the previous several years, the Company
recorded a full valuation allowance against the deferred tax assets in fiscal
year 2005. In the third quarter of fiscal year 2007, the Company reversed $6.3
million of that valuation allowance, due to the significant income the Company
has earned in the past two years, and the expectations of future taxable income
in 2008 being more likely than not sufficient to realize that amount of tax
asset. Due to the inherent risk in estimates of future earnings, the amount of
the valuation allowance continues to be subject to variability in the future,
and may significantly affect the Companys effective tax rate.
The Company adopted the provisions of FASB
Interpretation 48 (FIN 48) Accounting for Uncertainty in Income Taxes on
the first day of fiscal year 2007. As a result of the implementation of FIN 48,
the Company recognized a $352,000 increase to its liability for uncertain tax
positions, which was accounted for as an adjustment to the beginning balance of
retained earnings. Including the amount recognized upon adoption at December
30, 2006, the Company had approximately $2.9 million of liabilities for
unrecognized tax positions included in taxes payable in the accompanying
consolidated balance sheet at September 28, 2007, all of which, if recognized,
would favorably affect the Companys effective income tax rate.
The Company recognizes interest related to
uncertain tax positions as part of interest expense, and penalties as a
component of income tax expense. As of the first day of fiscal year 2007, the
Company had accrued interest and penalty of approximately $500,000 associated
with its uncertain tax positions. During the three and nine months ended
September 28, 2007, the Company recorded an additional $91,000 and $192,000 of
interest for uncertain tax positions within interest expense.
The Company files a consolidated federal
income tax return and income tax returns with various states and foreign
countries. The Company is currently not under examination by the Internal
Revenue Service and is no longer subject to federal income tax examination for
years before 2003. However, the
17
Company is undergoing income tax audits with various states and the earliest
open tax year under examination in any such state is 1999.
Note 10
Health Plans Outsourcing Contract
In April 2006, the Company began a $12 million outsourcing contract in
the Health Plans segment. This contract requires the Company to complete a system
implementation prior to beginning the operations phase of the contract. Since
the fair value of the operations phase is difficult to objectively verify in
order to separately account for it under EITF 00-21, the Company is accounting
for the arrangement as a single outsourcing service arrangement. The
implementation phase of this contract is being accounted for as deferred cost,
and all revenue from the implementation will be
recognized
over the period of outsourcing operations. As
a result, the Company expects to receive approximately $8 million of cash which
is being accounted for as a customer advance prior to earning revenue on the
contract, and the Companys deferred costs on the balance sheet are increasing
accordingly. Management estimates that the implementation will be completed in
May 2008. With respect to the implementation services, there has been an
increase in cost and hours to complete the project, and the parties are
currently in discussions regarding a contract amendment, the result of which is
expected to be little to no profit on the contract. As of September 28, 2007, the Company had deferred $6.6 million of contract
costs and $4.4 million of customer advances under this contract.
Note 11
Subsequent
Event - Pending
Acquisition by Computer Sciences Corporation
On October 30, 2007, First Consulting
Group, Inc. and Computer Sciences Corporation (CSC), entered into an
Agreement and Plan of Merger, pursuant to which CSC will acquire all of the
outstanding stock of First Consulting Group for a purchase price of $13.00 per
share in cash, without interest.
Completion
of the merger is
subject
to customary
conditions, including the approval of First Consulting Groups shareholders,
the absence of any material adverse effect on its business and applicable
regulatory approvals. The merger is
expected to close in the first quarter of 2008.
Item 2. Managements Discussion and
Analysis of Financial Condition and Results of Operations
THE FOLLOWING
MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF
OPERATIONS CONTAINS FORWARD-LOOKING STATEMENTS WITHIN THE MEANING OF THE
PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995. SUCH FORWARD-LOOKING
STATEMENTS INVOLVE RISKS AND UNCERTAINTIES, INCLUDING THOSE SET FORTH IN ITEM
1A OF PART II OF THIS REPORT UNDER THE CAPTION RISK FACTORS, AND OTHER
REPORTS WE FILE WITH THE SECURITIES AND EXCHANGE COMMISSION. OUR ACTUAL RESULTS
COULD DIFFER MATERIALLY FROM THOSE ANTICIPATED IN THESE FORWARD-LOOKING
STATEMENTS.
Pending
Acquisition by Computer Sciences Corporation
On October 30, 2007, First Consulting
Group, Inc. and Computer Sciences Corporation (CSC), entered into an
Agreement and Plan of Merger, pursuant to
which
CSC will acquire all of our
outstanding stock for a purchase price of $13.00 per share in cash, without
interest. Completion of the merger is
subject to customary conditions, including the approval of our shareholders,
the absence of any material adverse effect on our business and applicable
regulatory approvals. The merger is
expected to close in the first quarter of 2008.
Overview
We provide
services primarily to providers, payors, government agencies, pharmaceutical,
biogenetic, and other healthcare organizations in North America, Europe, and
Asia. We generate substantially all of our revenues from fees for information
technology outsourcing services and professional services.
We typically bill for our services on an hourly or fixed-fee basis as
specified by the agreement with a particular client. In our consulting and
systems integration (CSI) businesses, we often bill our services on an hourly
basis, by multiplying the amount of time expended on each assignment by the
project hourly rate for the staff members assigned to the engagement. Fixed
fees, including outsourcing fees, are established on a per-assignment or
monthly basis and are based on several factors such as the size, scope,
complexity and duration of an assignment, the number of our employees required
to complete
18
the assignment, and the volume of
transactions or interactions. Revenues are generally recognized based on the
level of services performed, the amount of cost incurred on the assignment
versus the estimated total cost to complete the assignment, or on a
straight-line basis over the period of performance of service. Additionally, we
have been licensing a gradually increasing amount of our software products,
generally in conjunction with the customization and implementation of such
software products. Revenues from our software licensing and maintenance were
approximately 4.2% and 3.7% of our net revenues during the first nine months of
2007 and 2006, respectively. We expect our software licensing and related
implementation revenues to continue to grow incrementally in the near future.
Provisions are
made for estimated uncollectible amounts based on our historical experience. We
may obtain payment in advance of providing services. These advances are
recorded as customer advances and reflected as a liability on our balance sheet
until services are provided. Provisions for estimated losses on individual
contracts are made in the period in which the loss first becomes known.
Out-of-pocket
expenses billed and reimbursed by clients are included in total revenues, and
then deducted to determine revenues before reimbursements (net revenues). For
purposes of analysis, all percentages of revenues in this discussion are stated
as a percentage of net revenues, since we believe that this is the more
relevant measure of our business.
Cost of
services primarily consists of the salaries, bonuses, and related benefits of
client-serving staff, subcontractor expenses, and infrastructure costs related
to services provided to clients and in our offshore shared service center. Selling
expenses primarily consist of the salaries, benefits, travel, and other costs
of our sales force, as well as marketing and market research expenses. General
and administrative expenses primarily consist of costs to support our business
such as non-billable travel, internal information systems and infrastructure,
salaries and expenses for executive management, financial accounting and
administrative personnel, and legal and other professional services. As staff
related costs are relatively fixed in the short term, variations in our
revenues and operating results in our CSI business can occur as a result of
variations in billing margins and utilization rates of our billable associates.
Our most significant expenses are our human
resource and related salary and benefit expenses. As of September 28, 2007,
approximately 1,554 of our 2,492 employees are billable consultants and
software developers. Another 588 employees are part of our outsourcing business.
The salaries and benefits of such billable staff and outsourcing related
employees are recognized in our cost of services. Most non-billable employee
salaries and benefits are recognized as a component of either selling or
general and administrative expenses. Approximately 14.0% of our workforce, or
350 employees, are classified as non-billable. Our cost of services as a
percentage of net revenues is directly related to several factors, including,
but not limited to:
Our staff
utilization, which is the ratio of total billable hours to available work hours
in a given period;
The amount and
timing of costs incurred;
Our ability to
control costs on our outsourcing projects;
The billed rate
on time and material contracts; and
The estimated
cost to complete our non-outsourcing fixed price contracts.
In our outsourcing contracts, a significant
portion of our revenues are fixed and allocated over the contract on a
straight-line basis, as we are required to provide a specified level of ongoing
services. Also, certain revenues may fluctuate under the contracts based on the
volume of transactions we process or other measurements of service provided. If
we incur higher costs to provide the required services or receive less revenue
due to reduced transaction volumes or penalties associated with service level
failures, our gross profit can be negatively impacted.
19
In our CSI
business, we manage staff utilization by monitoring assignment requirements and
timetables, available and required skills, and available staff hours per week
and per month. Differences in personnel utilization rates can result from
variations in the amount of non-billed time, which has historically consisted
of training time, vacation time, time lost to illness and inclement weather,
and unassigned time. Non-billed time also includes time devoted to other
necessary and productive activities such as sales support and interviewing
prospective employees. Unassigned time results from differences in the timing
of the completion of an existing assignment and the beginning of a new
assignment. In order to reduce and limit unassigned time, we actively manage
personnel utilization by monitoring and projecting estimated engagement start
and completion dates and matching staff availability with current and projected
client requirements. The number of people staffed on an assignment will vary
according to the size, complexity, duration, and demands of the assignment. Assignment
terminations, completions, inclement weather, and scheduling delays may result
in periods in which staff members are not optimally utilized. An unanticipated
termination of a significant assignment or an overall lengthening of the sales
cycle could result in a higher than expected number of unassigned staff members
and could cause us to experience lower margins. In addition, entry into new
market areas and the hiring of staff in advance of client assignments have
resulted and may continue to result in periods of lower staff utilization.
In response to
competition and continued pricing and rate pressures, we have implemented a
global sourcing strategy into our business operations, which includes the
deployment of offshore resources as well as resources that perform services
remote from the client site. We also incorporate larger numbers of variable
cost or per diem staff in some of our projects. We expect these strategies to
continue to reduce cost of services through a combination of lower cost
attributable to offshore resources and higher leverage of resources that
perform services offsite or on a variable cost basis. To the extent we pass
through reduced costs to our clients related to offshore resources, the global
sourcing strategy may result in lower revenues on a per engagement basis.
However, we expect to offset this potential revenue impact with improved
competitive positioning in our markets, which could result in an increased
number of engagements to offset the potential revenue impact. Several of our
competitors employ both global sourcing and variable staffing strategies to
provide software development and other information technology services to their
clients, while at the same time reducing their cost structure and improving the
quality of services they provide. If we are unable to realize the perceived
cost benefits of our strategies or if we are unable to deliver quality
services, our business may be adversely impacted and we may not be able to
compete effectively.
Results of Operations for the Three Months Ended September 28, 2007 and
September 29, 2006
Revenues.
Our net revenues were $66.8 million for the
quarter ended September 28, 2007, an increase of 3.2% from $64.8 million for
the quarter ended September 29, 2006. Our total revenues were $70.6 million for
the quarter ended September 28, 2007, an increase of 3.7% from $68.1 million
for the quarter ended September 29, 2006. The Health Plans segment had the most
significant increase in net revenues compared to the quarter ended September
29, 2006, $1.3 million, or 16.5%, primarily due to market acceptance of our
global delivery model by mid-size and large health plans. Health Delivery
Services revenues increased by $949,000, or 6.7% from a relatively weak quarter
in the prior year. Software Services declined by $1.1 million, or 15.0%, as
several of our larger clients have been acquired by other entities or reduced
their scope of operations utilizing our services over the past year.
One of our existing major
outsourcing contracts, University of Pennsylvania Health System (UPHS), expired
on March 31, 2007, and UPHS informed us in April 2007 that the contract would
not be renewed. Under the terms of the contract, the engagement automatically
converted to a six-month period of post-expiration transition services, which
were concluded at the end of September 2007, at which time most of the services
we were performing on an outsourced basis transitioned back to the client. The
expiring contract accounted for $26.7 million of our revenues in fiscal
year 2006 and $7.5 million and
20
$23.5 million of our revenues in the three and nine months of 2007, of
which $5.3 million, $1.2 million, and $3.4 million, respectively, were
zero-margin, pass-through revenues to a major infrastructure subcontractor. We
expect to retain only about $500,000 per quarter of revenues from UPHS under a
new contract for ongoing services. As a result, we expect significantly lower
revenues in our Health Delivery Outsourcing business unit starting in the
fourth quarter of 2007.
Revenues in our other
business units are not expected to change significantly from current levels in
the near future, with some growth expected in Life Sciences and Health Plans. Growth
in Health Delivery Services and in Health Delivery Outsourcing (exclusive of
the UPHS contract) is highly dependent on capturing market share through our
restructured sales model and acceptance by the health delivery market of our
global delivery model and clinical advisory services. We expect that the
current lower level of Software Services revenues we have experienced so far in
this fiscal year to continue in the near future. The market for our services in
this business segment is extremely competitive and we are seeking new clients
and new markets (such as overseas markets) to grow revenues back to their previous
levels.
Cost of Services.
Cost of services before reimbursable expenses
was $47.8 million for the quarter ended September 28, 2007, an increase of 3.0%
from $46.4 million for the quarter ended September 29, 2006. The increase was
primarily due to a $1.4 million increase in costs in the Health Delivery
Services segment for additional resources to serve the increase in revenues in
that segment, partly offset by a $382,000 decrease in costs in Software
Services as resources were reduced in response to the lower level of revenues. Additionally,
Other cost of services grew by $483,000 due to lower absorption of shared
service center costs. This was primarily due to currency appreciation of over
15% of the Indian rupee versus the United States dollar, increasing the cost of
Indian resources when translated to dollars. If the rupee continues to
appreciate in value against the dollar, our ability to provide cost competitive
services from our Indian offshore development center could be negatively
affected.
Gross
Profit.
Gross profit
was $19.0 million, or 28.5% of net revenues, for the quarter ended September
28, 2007, an increase of 3.7% from $18.4 million, or 28.3% of net revenues, for
the quarter ended September 29, 2006. This increase was primarily due to $1.2
million of increased gross profit in the Health Plan segment related to the
increase in revenues.
We
expect to see significantly lower gross profit in Health Delivery Outsourcing
in the fourth quarter of this year due to the completion of the UPHS contract,
as described above. This contract had a higher than normal gross profit of $1.4
million in the third quarter of 2007, due to transition activities related to
completion of the project.
Selling Expenses.
Selling expenses were $3.8 million for the
quarter ended September 28, 2007, a decrease of 3.2% from $3.9 million for the
quarter ended September 29, 2006. Selling expenses as a percentage of net
revenues decreased slightly to 5.7% for the quarter ended September 28, 2007
from 6.1% for the quarter ended September 29, 2006.
General and Administrative
Expenses.
General and
administrative expenses were $10.2 million for the quarter ended September 28,
2007, an increase of 16.6% from $8.8 million for the quarter ended September
29, 2006. General and administrative expenses as a percentage of net revenues
increased to 15.3% for the quarter ended September 28, 2007 from 13.5% for the
quarter ended September 29, 2006. General and Administrative expenses grew $1.0
million in Life Sciences, primarily related to spending on our FirstPoint
TM
product subsequent to the acquisition of Zorch, Inc. in June 2007. Additionally,
we spent approximately $600,000 during the third quarter of 2007 on legal costs
associated with the Company's process to enter into a merger agreement, which
was signed on October 30, 2007. (see Note 11 of Notes to Consolidated Financial
Statements).
21
Interest Income, Net.
Interest income, net of interest expense, was
$976,000 for the quarter ended September 28, 2007, an increase of 51.1% from
$646,000 for the quarter ended September 29, 2006, primarily due to higher
interest rates earned on higher cash and investments balances. Interest income,
net of interest expense, as a percentage of net revenues increased to 1.5% for
the quarter ended September 28, 2007 from 1.0% for the quarter ended September
29, 2006.
Other Income (Expense), Net
. Other income (expense) was negligible for
the quarters ended September 28, 2007 and September 29, 2006.
Income Taxes.
We recorded a $4.6 million tax benefit for
the quarter ended September 28, 2007, compared to a $454,000 tax provision for
the quarter ended September 29, 2006. The benefit in the current quarter is due
to a $1.8 million provision (29.3% tax rate) on pretax income for the quarter,
and a $6.3 million tax benefit due to the reversal of valuation allowance. This
reversal is due to the realization of our remaining deferred tax assets
becoming more likely than not based on the significant pretax income we are now
generating and managements estimate of continuing profitability in 2008. The
7.3% tax provision for the quarter ended September 29, 2006 was only for
current taxes payable for U.S. federal alternative minimum tax and certain
state and foreign income taxes, as our net operating loss carryforwards, which
were fully reserved, offset most of the federal and certain state tax
liabilities.
Our estimated tax rate in fiscal year 2007 of 28% on continuing
operations has increased significantly from the rate experienced in fiscal year
2006 as we have exhausted our remaining tax loss carryforwards over the course
of this year. We expect that our tax provision in 2008 and thereafter will
return to levels consistent with statutory federal and state tax rates. During
this 2007 transition, when our loss carryforwards cover only a part of our
expected pretax income, our full year tax rate is subject to variation from
quarter to quarter, as changes in our estimated level of pretax income can
significantly impact the tax rate.
Income from Discontinued Operations.
We completed the sale of the Software
Products business on September 12, 2007 and the disposition has been accounted
for as a discontinued operation. We had income from discontinued operations of
$10.0 million in the quarter ended September 28, 2007, compared to income from
discontinued operations of $288,000 in the quarter ended September 29, 2006. We
received $13.8 million in cash from the sale resulting in a pretax gain from
the disposition of discontinued operations of $17.1 million, which includes certain
software subscription revenue we had deferred as a customer advance, net of the
related deferred costs.
In August 2006, we sold the Cyberview software product and related
intellectual property and service contracts to Medisolv, Inc and recognized
$691,000 of pretax gain from the disposition of discontinued operation for the
three months ended September 29, 2006. During the quarter ended September 28,
2007, we incurred an $824,000 pretax operating loss from this discontinued
operation, compared to a $399,000 pretax operating loss for the quarter ended
September 29, 2006. We applied a 38.3% incremental tax rate to the discontinued
operations in fiscal year 2007 compared to a 1.4% rate in fiscal year 2006 due
to the use of net operating loss carryforwards available in that year. We do
not expect any significant future gain or loss related to the discontinuance of
the Software Products segment of our business.
Results of Operations for the Nine months Ended September 28, 2007 and
September 29, 2006
Revenues.
Our net revenues were $200.0 million for the
nine months ended September 28, 2007, an increase of 2.5% from $195.2 million
for the nine months ended September 29, 2006. Our total revenues were $210.7
million for the nine months ended September 28, 2007, an increase of 2.4% from
$205.8 million for the nine months ended September 29, 2006. The increases in
net revenues were in Health Plans, Health Delivery Outsourcing, and Life
Sciences, and offset by decreases in Software
22
Services and Health Delivery Services. Health Plans revenues increased
by $3.1 million, or 14.0%, due to increased market acceptance of our global
delivery model by mid-size and large health plans. Health Delivery Outsourcing
revenues grew by $3.1 million, or 3.8%, due to slightly higher revenues at
existing accounts and transition services on a terminated contract. Life
Sciences net revenues increased by $2.7 million, or 10.9%, due to more
extensive implementation work being performed for our FirstDoc® software
clients. Software Services revenues decreased by $1.9 million, or 9.2%, as
several of our larger clients have been acquired by other entities or reduced
their scope of operations utilizing our services over the past year.
Cost of Services.
Cost of services before reimbursable expenses
was $145.3 million for the nine months ended September 28, 2007, an increase of
3.4% from $140.6 million for the nine months ended September 29, 2006. The
increase was primarily due to a $2.4 million increase in costs in the Health
Delivery Outsourcing segment, a $1.9 million increase in costs in the Health
Plans segment, and a $1.1 million increase in costs in the Health Delivery
segment, all directly related to the respective increases in revenues in those
segments described above. Additionally, Software Services cost of services
increased by $784,000, because labor costs increased in the early part of this
year due to the loss of higher margin projects and their replacement with lower
margin projects which require more resources to achieve the same revenues. These
increases are partially offset by a $1.7 million decrease in Life Sciences
labor and other costs due to improved efficiency in performing Life Sciences
implementation projects.
Gross Profit.
Gross profit was $54.7 million,
or 27.3% of net revenues, for the nine months ended September 28, 2007, a
slight increase of 0.1% from $54.6 million, or 28.0% of net revenues, for the
nine months ended September 29, 2006. This was a result of increases in gross
profit in Life Sciences and Health Plans, offset by decreases in Software
Services and Health Delivery Services. Gross profit increased by $4.3 million
in Life Sciences due to increased revenues and decreased costs as described
above. Health Plans gross profit increased by $1.3 million due to the increase
in revenues. Software Services gross profit decreased by $2.7 million and
Health Delivery Services gross profit decreased by $1.9 million, in both cases
due to a combination of a revenue decline and a modest cost increase, as
described above.
Selling Expenses.
Selling expenses were $11.7 million for the
nine months ended September 28, 2007, a slight decrease of 3.1% from $12.1
million for the nine months ended September 29, 2006. Selling expenses as a
percentage of net revenues also decreased to 5.9% for the nine months ended
September 28, 2007 from 6.2% for the nine months ended September 29, 2006.
General and Administrative
Expenses.
General and
administrative expenses were $29.5 million compared to $26.9 million for the
nine months ended September 29, 2006. This is primarily due to a $1.6 million
charge in the second quarter of 2007 for acquired in-process research and
development expense related to the Zorch acquisition (see Note 4 of Notes to
Consolidated Financial Statements). Excluding this item, general and
administration expenses would have increased 3.8% to $27.9 million for the nine
months ended September 28, 2007 from $26.9 million for the nine months ended
September 29, 2006. General and administrative expenses as a percentage of net
revenues were 14.7% of revenues for the nine months ended September 28, 2007,
but would have increased slightly to 13.9% for the nine months ended September
28, 2007 from 13.8% for the nine months ended September 29, 2006, exclusive of
the in-process research and development charge from the Zorch acquisition.
Interest Income, Net.
Interest income, net of interest expense, was
$2.8 million for the nine months ended September 28, 2007, an increase of 96.6%
from $1.4 million for the nine months ended September 29, 2006, due to higher
interest rates earned on higher cash and investments balances. Interest income,
net of interest expense, as a percentage of net revenues increased to 1.4% for
the nine months ended September 28, 2007 from 0.7% for the nine months ended
September 29, 2006.
23
Other Income (Expense), Net
. Other income (expense) was negligible for
the nine months ended September 28, 2007 and September 29, 2006.
Income Taxes.
We recorded a $1.8 million tax benefit for
the nine months ended September 28, 2007, compared to a $1.2 million tax
provision for the nine months ended September 29, 2006. The benefit in the nine
months of 2007 is due to a $4.6 million provision (28.0% tax rate) on pretax
income for the nine months, and a $6.3 million tax benefit due to the reversal
of valuation allowance in the third quarter of the year. This reversal is due to
the realization of our remaining deferred tax assets becoming more likely than
not based on the significant pretax income we are now generating and managements
estimate of continuing profitability in 2008. The 7.0% tax provision for the
nine months ended September 29, 2006 was only for current taxes payable for
U.S. federal alternative minimum tax and certain state and foreign income
taxes, as our net operating loss carryforwards, which were fully reserved,
offset most of the federal and certain state tax liabilities.
Income from Discontinued Operations.
We completed the sale of the Software
Products business on September 12, 2007 and the disposition has been accounted
for as a discontinued operation. We had income from discontinued operations of
$9.4 million in the nine months ended September 28, 2007, compared to a loss
from discontinued operations of $47,000 in the nine months ended September 29,
2006. We received $13.8 million in cash from the sale resulting in a pretax
gain from the disposition of discontinued operations of $17.1 million, which
includes certain software subscription revenue we had deferred as a customer
advance, net of the related deferred costs.
In August 2006, we sold the Cyberview software product and related
intellectual property and service contracts to Medisolv, Inc and recognized
$694,000 of pretax gain from the disposition of discontinued operation for the
nine months ended September 29, 2006. During the nine months ended September
28, 2007, we incurred a $1.9 million pretax operating loss from this
discontinued operation, compared to a $739,000 pretax operating loss for the
nine months ended September 29, 2006. We applied a 38.3% incremental tax rate
to the discontinued operations in fiscal year 2007 compared to a 1.4% rate in
fiscal year 2006 due to the use of net operating loss carryforwards available
in that year.
Liquidity and Capital Resources
At September 28, 2007, we had cash and
investments available for sale of $98.4 million compared to $63.5 million at
December 29, 2006. During the nine months ended September 28, 2007, we
generated cash flow from operations of $21.0 million which primarily consisted
of $18.0 million of net income from continuing operations. Additionally, our
cash flow benefited from $4.2 million of stock option exercises.
Our days sales outstanding (DSO) of accounts
receivable (including unbilled receivables and customer advances) increased to
33 days for the third quarter of 2007 from 31 days for the fourth quarter of
2006. We expect our DSO to increase in the fourth quarter of this year due to
the completion of the UPHS contract (see Results of Operations Revenues),
since that contract comprised over 10% of revenues, but very little accounts
receivable. We do not currently anticipate any other significant changes in DSO.
During the fourth quarter, we expect to pay approximately $9 million of income
taxes, primarily related to the gain on the sale of discontinued operations,
but also related to our pretax income from continuing operations as we have
exhausted our net operating loss carryforwards. We do not currently expect any
other significant cash flow changes related to the other elements of the
working capital cycle such as accounts payable and accrued liabilities;
however, we are susceptible to ongoing routine fluctuations in these areas.
24
We used $2.5 million of cash during the nine
months ended September 28, 2007 to purchase property and equipment, primarily
information technology and related equipment, while incurring approximately
$4.5 million of depreciation and amortization.
We used $2.0 million of cash in June 2007 for
the purchase of Zorch (see Note 4 of Notes to Consolidated Financial
Statements). Additionally, up to $2.0 million of additional payments may become
payable to the previous shareholders of Zorch within the next year based on the
achievement of certain revenue targets related to the acquired business, and
additional amounts may become payable in future years if operating income from
the acquired business exceeds 14% of revenues during an earnout period that
commences in the second half of 2008 and ends in the first quarter of 2011.
Our cash flow in fiscal year 2007 is highly
dependent on our ability to continue to be profitable. Generally, we expect any
net profitability in fiscal year 2007 to contribute positively to cash flow.
As of September 28, 2007, the following table
summarizes our contractual commitments (in thousands):
|
|
Payments Due by Period
|
|
Contractual Obligation
|
|
Less than 1
Year
|
|
1 - 3
Years
|
|
3 - 5
Years
|
|
Total
|
|
Operating
leases, net of subleases
|
|
$
|
3,395
|
|
$
|
3,870
|
|
$
|
2,264
|
|
$
|
9,529
|
|
Purchase
obligations
|
|
599
|
|
352
|
|
|
|
951
|
|
Total
|
|
$
|
3,994
|
|
$
|
4,222
|
|
$
|
2,264
|
|
$
|
10,480
|
|
Additionally,
as of September 28, 2007, we had $2.9 million of current liabilities in the
consolidated balance sheet for unrecognized tax positions. However, the periods
of cash settlement with the respective tax authorities cannot be reasonably
estimated.
Management believes that our existing cash
and cash equivalents, together with funds generated from operations, will be
sufficient to meet operating requirements for at least the next twelve months. Our
cash and cash equivalents are available for capital expenditures (which are projected
at approximately $5 million for 2007), upfront setup costs and deferred fees on
new contracts, strategic investments, mergers and acquisitions (including the
additional payments related to the Zorch acquisition), and other potential
large-scale cash needs that may arise. In addition, we may consider incurring
indebtedness or issuing debt or equity securities in the future to fund
potential acquisitions or investments, or for general corporate purposes.
Off-Balance Sheet Arrangements
None.
Critical Accounting Policies and Estimates
The foregoing
discussion and analysis of our financial condition and results of operations is
based upon our consolidated financial statements, which have been prepared in
accordance with accounting principles generally accepted in the United States. The
preparation of these financial statements requires us to make estimates and
assumptions that affect the reported amounts of assets, liabilities, revenues
and expenses, and related disclosure of contingent assets and liabilities. On
an ongoing basis, we evaluate our estimates, including those related to revenue
recognition, cost to complete client engagements, valuation of goodwill and
long-lived and intangible assets, accrued liabilities, income taxes,
restructuring costs, idle facilities, litigation and disputes, and the
allowance for doubtful accounts. We base our estimates on historical experience
and on various other assumptions that we believe to be reasonable under the
25
circumstances, the results of which form the
basis for making judgments about the carrying value of assets and liabilities
that are not readily apparent from other sources. Our actual results may differ
from our estimates and we do not assume any obligation to update any
forward-looking information.
We believe the
following critical accounting policies reflect our more significant assumptions
and estimates used in the preparation of our consolidated financial statements.
Revenue Recognition, Accounts
Receivable, and Unbilled Receivables
Revenues are
derived primarily from information technology outsourcing services, consulting,
and systems integration. Revenues are recognized on a time-and-materials,
level-of-effort, percentage-of-completion, or straight-line basis. Before
revenues are recognized, the following four criteria must be met: (a)
persuasive evidence of an arrangement exists; (b) delivery has occurred or
services rendered; (c) the fee is fixed and determinable; and (d)
collectability is reasonably assured. We determine if the fee is fixed and
determinable and collectability is reasonably assured based on our judgments
regarding the nature of the fee charged for services rendered and products
delivered. Arrangements vary in length from less than one year to seven years. The
longer-term arrangements are generally level-of-effort or fixed price
arrangements.
Revenues from
time-and-materials arrangements are generally recognized based upon contracted
hourly billing rates as the work progresses. Revenues from level-of-effort
arrangements are recognized based upon a fixed price for the level of resources
provided. Revenues from fixed fee arrangements for consulting and systems
integration work are generally recognized on a rate per hour or percentage-of-completion
basis. We maintain, for each of our fixed fee contracts, estimates of total
revenue and cost over the contract term. For purposes of periodic financial
reporting on the fixed price consulting and system integration contracts, we
accumulate total actual costs incurred to date under the contract. The ratio of
those actual costs to our then-current estimate of total costs for the life of
the contract is then applied to our then-current estimate of total revenues for
the life of the contract to determine the portion of total estimated revenues
that should be recognized. We follow this method because reasonably dependable
estimates of the revenues and costs applicable to various stages of a contract
can be made.
Revenues
recognized on fixed price consulting and system integration contracts are
subject to revisions as the contract progresses to completion. If we do not
accurately estimate the resources required or the scope of the work to be
performed, do not complete our projects within the planned periods of time, or
do not satisfy our obligations under the contracts, then profit may be
significantly and negatively affected. Revisions in our contract estimates are
reflected in the period in which the determination is made that facts and
circumstances dictate a change of estimate. Favorable changes in estimates
result in additional revenues recognized, and unfavorable changes in estimates
result in a reduction of recognized revenues. Provisions for estimated losses
on individual contracts are made in the period in which the loss first becomes
known. At September 28, 2007, we did not identify any contracts that required
an accrual for losses. Some contracts include incentives for achieving either
schedule targets, cost targets, or other defined goals. Revenues from incentive
type arrangements are recognized when it is probable they will be earned.
We account for
certain of our outsourcing contracts using EITF 00-21, Accounting for Revenue
Arrangements with Multiple Deliverables, which addresses how to account for
arrangements that involve the delivery or performance of multiple products,
services, and/or rights to use assets. Revenue arrangements with multiple
deliverables are divided into separate units of accounting if the deliverables
in the arrangement meet the following criteria: (1) the delivered item has
value to the customer on a standalone basis; (2) there is objective and
reliable evidence of the fair value of undelivered items; and (3) delivery
of any undelivered item is probable. Arrangement consideration is allocated
among the separate units of accounting based on their relative fair values,
with the amount allocated to the delivered
26
item being limited to the amount that is not
contingent on the delivery of additional items or meeting other specified
performance conditions.
In our
outsourcing contracts, a significant portion of our revenues are fixed and
allocated over the contract on a straight-line basis, as we are required to
provide a specified level of services subject to certain performance
measurements. Also, certain revenues may fluctuate under the contracts based on
the volume of transactions we process or other measurements of service provided.
If we incur higher costs to provide the required services or receive lower
revenues due to reduced transaction volumes or penalties associated with
service level failures, our gross profit can be negatively impacted.
On certain
contracts, or elements of contracts, costs are incurred subsequent to the
signing of the contract, but prior to the rendering of service and associated
recognition of revenue. Where such costs are incurred and realization of those
costs is either paid for upfront or guaranteed by the contract, those costs are
deferred and later expensed over the period of recognition of the related
revenue. At September 28, 2007 and December 29, 2006, we had deferred $8.7
million and $5.3 million, respectively, of unamortized costs which are included
in non-current assets.
In April 2006,
we began a $12 million outsourcing contract in the Health Plans segment. This
contract requires us to complete a system implementation prior to beginning the
operations phase of the contract. Since the fair value of the operations phase
is difficult to objectively verify in order to separately account for it under
EITF 00-21, we are accounting for the arrangement as a single outsourcing
service arrangement. The implementation phase of this contract is being
accounted for as deferred cost, and all revenue from the implementation will be
recognized over the period of outsourcing operations. As a result, we expect to
receive approximately $7 million of cash which is being accounted for as a
customer advance prior to earning revenue on the contract, and our deferred
costs on the balance sheet are increasing accordingly. We estimate that the
implementation will be completed in May 2008. With respect to the
implementation services, there has been an increase in cost and hours to
complete the project, and the parties are currently in discussions regarding a
contract amendment, the result of which is expected to be little to no profit
on the contract. As of September 28, 2007, we had deferred $6.6 million of contract
costs and $4.4 million of customer advances under this contract.
As part of our
ongoing operations to provide services to our customers, incidental expenses,
which are generally reimbursable under the terms of the contracts, are billed
to customers. These expenses are recorded as both revenues and direct cost of
services in accordance with the provisions of EITF 01-14, Income Statement
Characterization of Reimbursements Received for Out-of-Pocket Expenses
Incurred and include expenses such as airfare, mileage, hotel stays,
out-of-town meals, and telecommunication charges.
Software
license and maintenance revenues comprised 4.2% of our net revenues for the
nine months ended September 28, 2007. Additionally, we realized additional
revenues from the implementation of our software. We recognize software
revenues in accordance with the provisions of the American Institute of
Certified Public Accountants Statement of Position (SOP) 97-2, Software
Revenue Recognition, as amended by SOP 98-9, Modification of SOP 97-2,
Software Revenue Recognition, With Respect to Certain Transactions, and in
accordance with the Securities and Exchange Commission Staff Accounting
Bulletin (SAB) 104, Revenue Recognition. We license software under
non-cancelable license agreements and provide related professional services,
including consulting, training, and implementation services, as well as ongoing
customer support and maintenance. Most of our software license fee revenues are
from arrangements which include implementation services that are essential to
the functionality of our software products, and are recognized using contract
accounting, including the percentage-of-completion methodology, over the period
of the implementation.
27
In those more
limited cases where our software arrangements do not include services essential
to the functionality of the product, license fee revenues are recognized when
the software product has been shipped, provided a non-cancelable license
agreement has been signed, there are no uncertainties surrounding product
acceptance, the fees are fixed or determinable and collection of the related
receivable is considered probable. We do not generally offer rights of return
or acceptance clauses to our customers. In situations where we do provide
rights of return or acceptance clauses, revenue is deferred until the clause
expires. Typically, our software license fees are due within a twelve-month
period from the date of shipment. If the fee due from the customer is not fixed
or determinable, including payment terms greater than twelve months from
shipment, revenue is recognized as payments become due and all other conditions
for revenue recognition have been satisfied. In software arrangements that
include rights to multiple software products, specified upgrades, maintenance
or services, we allocate the total arrangement fee among the deliverables using
the fair value of each of the deliverables determined using vendor-specific
objective evidence. Vendor-specific objective evidence of fair value is
determined using the price charged when that element is sold separately. In
software arrangements in which we have fair value of all undelivered elements
but not of a delivered element, we use the residual method to record revenue.
Under the residual method, the fair value of the undelivered elements is
deferred and the remaining portion of the arrangement fee is allocated to the
delivered element(s) and is recognized as revenue. In software arrangements in
which we do not have vendor-specific objective evidence of fair value of all
undelivered elements, revenue is deferred until fair value is determined or all
elements have been delivered, or is spread over the term of an arrangement as a
subscription.
Revenues from
training and consulting services are recognized as services are provided to
customers. Revenues from maintenance contracts are deferred and recognized
ratably over the term of the maintenance agreements. Revenues for customer
support and maintenance that are bundled with the initial license fee are
deferred based on the fair value of the bundled support services and recognized
ratably over the term of the agreement; fair value is based on the renewal rate
for continued support arrangements.
At September
28, 2007 and December 29, 2006, we had unbilled receivables of $17.8 million
and $12.1 million, respectively, which represent revenues recognized for
services performed that were not billed at the balance sheet date. The majority
of these amounts are billed in the subsequent month; however, certain
unbillable amounts arising from contracts occur when revenues recognized exceed
allowable billings in accordance with the contractual agreements. Such
unbillable amounts most often become billable upon reaching certain project
milestones stipulated per the contract, or in accordance with the percentage of
completion methodology. As of September 28, 2007, we had unbillable amounts of
approximately $3.3 million, which are generally expected to be billed within
one year.
We had
long-term accounts receivable at September 28, 2007 and December 29, 2006 of
$2.3 million and $2.4 million. Of the long-term account receivable of $2.3
million at September 28, 2007, $1.3 million was created in August 2005 through
the deferral until 2009 of the first month of fees of a new outsourcing
contract. In January 2006, an additional amount of approximately $800,000
related to this contract was deferred until 2009. Both deferrals were in
accordance with the terms of the contract executed with this client in July
2005. Imputed interest income at a rate of 7.0% of $119,000 was accrued during
the first nine months of 2007 on this receivable. Unamortized discount of
$398,000 remained at September 28, 2007.
Customer
advances are comprised of payments from customers for which services have not
yet been performed or prepayments against work in process. These unearned
revenues are deferred and recognized as future contract costs are incurred and
as contract services are rendered.
28
Allowance for Doubtful Accounts
We maintain an allowance for doubtful
accounts for estimated losses resulting from the inability of our clients to
make required payments. This allowance is based on the amount and aging of our
accounts receivable, creditworthiness of our clients, historical collection
experience, current economic trends, and changes in client payment patterns. If
the financial condition of our clients was to deteriorate, resulting in an
impairment of their ability to make payments, additional allowances would be
required. Our bad debt losses have generally been moderate due to the size and
quality of our customers; however, we have recently incurred some bad debt
losses in our growing Software Services segment due to the lower credit quality
of our clients in that segment. Should one of our larger clients unexpectedly
become unable to pay us, our allowance would have to increase significantly. Our
allowance for doubtful accounts at September 28, 2007 and December 29, 2006
included specific reserves of approximately $537,000 and $899,000, respectively
for identified customer balances that are uncertain of collection, primarily
two accounts in our Software Services segment, and a general reserve of
approximately $750,000 for unknown losses.
Deferred Income
Taxes
We account for income taxes in accordance
with SFAS 109, Accounting for Income Taxes, which requires recognition of
deferred tax assets and liabilities for the expected future tax consequences of
events that have been included in the financial statements which differ from
our tax returns. We use significant estimates in determining what portion of
our deferred tax asset is more likely than not to be realized. We have also
recorded a provision for uncertain tax positions in accordance with FIN 48, Accounting
for Uncertainty in Income Taxes, based on managements estimate of potential
tax liabilities for open tax years.
Our valuation allowance for deferred income
taxes has been a particularly volatile estimate over the past four years, as
our level of income and loss has fluctuated, requiring us to reassess the
likelihood of realization of our tax assets. Due to cumulative losses we had
incurred over the previous several years, we recorded a full valuation
allowance against our deferred tax assets in fiscal year 2005. In the third
quarter of fiscal year 2007, we reversed $6.3 million of that valuation
allowance, due to the significant income we have earned in the past two years,
and our expectations of future taxable income in 2008 being more likely than
not sufficient to realize that amount of tax asset. Due to the inherent risk in
estimates of future earnings, the amount of our valuation allowance continues
to be subject to variability in the future, and may significantly affect our
effective tax rate.
Goodwill and
Intangible Assets
Under SFAS
142, we complete an annual impairment testing which is performed during the
fourth quarter of each year. We believe that the accounting assumptions
and estimates related to the annual goodwill impairment testing are critical
because these can change from period to period. Various assumptions, such
as discount rates, and comparable company analysis are used in performing these
valuations. The impairment test requires us to forecast our future cash flows,
which involves significant judgment. Accordingly, if our
expectations of future operating results change, or if there are changes to
other assumptions, our estimate of the fair value of our reporting units could
change significantly resulting in a goodwill impairment charge, which could
have a significant impact on our consolidated financial statements. We
performed an impairment test on each of our components of goodwill as of the
fourth quarter of fiscal year 2006 and determined that none of our goodwill was
impaired. As of September 28, 2007, we have $18.0 million of goodwill and
$170,000 of amortizable intangible assets recorded on our balance sheet (see
Note 5 of the Notes to Consolidated Financial Statements included in this
report).
29
Recent Accounting
Pronouncements
In
September 2006 and February 2007, respectively, the FASB issued SFAS 157, Fair
Value Measurements and SFAS 159, The Fair Value Option of Financial Assets
and Financial Liabilities (see Recent Accounting Pronouncements in Note 1 of
the financial statements in Item 1 of this report).
In June 2006,
the FASB issued FASB Interpretation 48, Accounting for Uncertainty in Income
Taxes (see Recent Accounting Pronouncements in Note 1 of the financial
statements in Item 1 of this report).
Item 3. Quantitative and Qualitative Disclosures
about Market Risk
Our financial
instruments include cash and cash equivalents, short-term and long-term
investments, accounts receivable, unbilled receivables, and accounts payable. Only
the cash and cash equivalents, and short-term and long-term investments which
totaled $98.4 million at September 28, 2007 present us with market risk
exposure resulting primarily from changes in interest rates. Based on
this balance, a change of one percent in the interest rate would cause a change
in interest income for the annual period of approximately $984,000. Our
objective in maintaining these investments is the flexibility obtained in
having cash available for payment of accrued liabilities and acquisitions.
Item 4. Controls and Procedures
We maintain
disclosure controls and procedures that are designed to ensure that information
required to be disclosed in our Exchange Act reports is recorded, processed,
summarized, and reported within the time periods specified in the Securities
and Exchange Commissions rules and forms, and that such information is
accumulated and communicated to our management, including our Chief Executive
Officer and Chief Financial Officer, as appropriate, to allow for timely
decisions regarding required disclosure. In designing and evaluating the
disclosure controls and procedures, management is required to apply its
judgment in evaluating the cost-benefit relationship of possible controls and
procedures. Our disclosure controls and procedures are designed to provide a
reasonable level of assurance of reaching our desired disclosure control
objectives.
As required by SEC Rule 13a-15(b), we carried out an
evaluation, under the supervision and with the participation of our management,
including our Chief Executive Officer and our Chief Financial Officer, of the
effectiveness of the design and operation of our disclosure controls and
procedures as of December 29, 2006. Based on the foregoing, our Chief Executive
Officer and Chief Financial Officer concluded that, except as indicated in the
paragraph below, our disclosure controls and procedures were effective, and
were operating at the reasonable assurance level.
As previously
disclosed in Item 9A to our Annual Report on Form 10-K for the fiscal year
ended December 30, 2005, our Chief Executive Officer and Chief Financial
Officer concluded that our disclosure controls and procedures were not
effective as of the end of that year because we did not maintain effective
controls over the determination and reporting of our provision for income
taxes, and we had a material weakness in internal controls as defined in
Audit Standard No. 2 adopted by the Public Company Accounting Oversight Board. In
August 2006, we hired a new tax director with experience in calculating
deferred tax assets, and in applying SFAS 109, Accounting for Income Taxes. The new tax director has improved the
process and review controls over the calculation of our tax provision since her
arrival. Because the tax provision is an annual process, and the new process
and review controls were implemented during the course of fiscal year 2006,
there has been insufficient time to validate that such controls and procedures
are operating at a level to have remediated the previous material weakness, and
that it therefore still existed as of December 29, 2006 and September 28, 2007.
30
Other than as described above, there has been no change
in our internal controls over financial reporting during our most recent fiscal
nine months that has materially affected, or is reasonably likely to materially
affect, our internal controls over financial reporting.
PART II. OTHER INFORMATION
Item 1. Legal Proceedings
From time to
time, we may be involved in claims or litigation that arise in the normal
course of business. We are not currently a party to any legal proceedings,
which, if decided adversely to us, would have a material adverse effect on our
business, financial condition, or results of operations.
Item 1A. Risk Factors
Except as set
forth below, there have been no material changes from risk factors as
previously disclosed in response to Item 1A in Part I of our 2006 10-K.
Failure to
complete the merger with Computer Sciences Corporation could negatively impact
our stock price and adversely affect our future financial condition,
operations, and prospects.
The proposed
merger with
Computer
Sciences Corporation ("CSC") is subject to the satisfaction of
closing conditions, including the approval by the holders of a majority of our outstanding
shares of common stock and other conditions described in the merger agreement. We
cannot be assured that these conditions will be satisfied or that the proposed
merger will be successfully completed. In the event that the proposed merger is
not completed:
Managements
attention from our day-to-day business may be diverted;
We may lose key
employees;
Our
relationships with our customers and business partners may be disrupted as a
result of uncertainties with regard to our business and prospects;
We may be
required to pay a termination fee of $10.9 million to CSC in specific
circumstances if the merger agreement is terminated;
We will be required
to pay significant transaction costs related to proposed merger, such as legal,
accounting, and other fees; and
The market price
of shares of our common stock may decline to the extent that the current market
price of those shares reflects a market assumption that the proposed merger
will be completed.
Any of these events could
adversely affect our stock price, business, cash flows, and operating results.
In addition, our current and
prospective employees may experience uncertainty about their future role with
CSC until CSCs strategies with regard to us are announced or executed. This
may adversely affect our ability to attract and retain key management,
consulting associates, sales and marketing and other personnel.
We intend to comply with the
securities and antitrust laws of the United States and any other jurisdiction
in which the proposed transaction is subject to review. The reviewing
authorities may seek to
31
impose conditions before giving their
approval or consent to the transaction. A delay in obtaining the necessary
regulatory approvals will delay the completion of the transaction. We have not
yet obtained any governmental or regulatory approvals required to complete the
transaction. We may be unable to obtain these approvals or to obtain them
within the timeframe contemplated by the merger agreement.
If the merger agreement is
terminated and our board of directors determines to seek another merger or
business combination, it may not be able to find a partner willing to pay an
equivalent or more attractive price than that which would have been paid in the
merger with CSC.
Item 2. Unregistered Sales of Equity Securities
and Use of Proceeds
None.
Item 3. Defaults Upon Senior Securities
None.
Item 4. Submission of Matters to a Vote of
Security Holders
None.
Item 5. Other Information
None.
Item 6. Exhibits
Item
|
|
Description
|
3.1 (1)
|
|
Certificate of Incorporation of the Company
|
3.1.1 (2)
|
|
Certificate of Amendment to Certificate of Incorporation of the
Company effective June 12, 2007
|
3.2 (3)
|
|
Certificate of Designation of Series A Junior Participating Preferred
Stock
|
3.3 (4)
|
|
Bylaws of the Company
|
3.3.1 (5)
|
|
Amendment to the Bylaws of the Company effective June 12, 2007
|
4.1 (6)
|
|
Specimen Common Stock Certificate
|
11.1 (7)
|
|
Statement of computation of per share earnings
|
31.1
|
|
Rule 13a-14(a)/Rule 15d-14(a) Certification of the Chief Executive
Officer
|
31.2
|
|
Rule 13a-14(a)/Rule 15d-14(a) Certification of the Chief Financial
Officer
|
32.1
|
|
Section 1350 Certification of the Chief Executive Officer
|
32.2
|
|
Section 1350 Certification of the Chief Financial Officer
|
(1)
Incorporated
by reference to Exhibit 3.1 to FCGs Form S-1 Registration Statement (No.
333-41121) originally filed on November 26, 1997 (the Form S-1).
(2)
Incorporated
by reference to Exhibit 3.1.1 to FCGs Quarterly Report on Form 10-Q for the
quarter ended June 29, 2007.
(3)
Incorporated
by reference to Exhibit 99.1 to FCGs Current Report on Form 8-K dated December
9, 1999.
32
(4)
Incorporated by
reference to Exhibit 3.3 to FCGs Form S-1.
(5)
Incorporated by
reference to Exhibit 3.3.1 to FCGs Quarterly Report on Form 10-Q for the
quarter ended June 29, 2007.
(6)
Incorporated by
reference to Exhibit 4.1 to FCGs Form S-1.
(7)
See Note 1 of Notes to
Consolidated Financial Statements, Basic and Diluted Net Income Per Share.
33
SIGNATURES
Pursuant to
the requirements of the Securities and Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned thereunto
duly authorized.
|
FIRST CONSULTING GROUP, INC.
|
|
|
|
|
Date: November 7, 2007
|
/s/LARRY R. FERGUSON
|
|
|
Larry R. Ferguson
|
|
Chief Executive Officer
|
|
|
|
|
Date: November 7, 2007
|
/s/THOMAS A WATFORD
|
|
|
Thomas A. Watford
|
|
Chief Operating Officer and Chief
|
|
Financial Officer
|
|
|
|
|
34
EXHIBIT INDEX
Item
|
|
Description
|
3.1 (1)
|
|
Certificate of Incorporation of the Company
|
3.1.1 (2)
|
|
Certificate of Amendment to Certificate of Incorporation of the
Company effective June 12, 2007
|
3.2 (3)
|
|
Certificate of Designation of Series A Junior Participating Preferred
Stock
|
3.3 (4)
|
|
Bylaws of the Company
|
3.3.1 (5)
|
|
Amendment to the Bylaws of the Company effective June 12, 2007
|
4.1 (6)
|
|
Specimen Common Stock Certificate
|
11.1 (7)
|
|
Statement of computation of per share earnings
|
31.1
|
|
Rule 13a-14(a)/Rule 15d-14(a) Certification of the Chief Executive
Officer
|
31.2
|
|
Rule 13a-14(a)/Rule 15d-14(a) Certification of the Chief Financial
Officer
|
32.1
|
|
Section 1350 Certification of the Chief Executive Officer
|
32.2
|
|
Section 1350 Certification of the Chief Financial Officer
|
(1)
Incorporated
by reference to Exhibit 3.1 to FCGs Form S-1 Registration Statement (No.
333-41121) originally filed on November 26, 1997 (the Form S-1).
(2)
Incorporated
by reference to Exhibit 3.1.1 to FCGs Quarterly Report on Form 10-Q for the
quarter ended June 29, 2007.
(3)
Incorporated
by reference to Exhibit 99.1 to FCGs Current Report on Form 8-K dated December
9, 1999.
(4)
Incorporated
by reference to Exhibit 3.3 to FCGs Form S-1.
(5)
Incorporated
by reference to Exhibit 3.3.1 to FCGs Quarterly Report on Form 10-Q for the
quarter ended June 29, 2007.
(6)
Incorporated
by reference to Exhibit 4.1 to FCGs Form S-1.
(7)
See
Note 1 of Notes to Consolidated Financial Statements, Basic and Diluted Net
Income Per Share.
35
First Consulting (NASDAQ:FCGI)
Historical Stock Chart
From Jan 2025 to Feb 2025
First Consulting (NASDAQ:FCGI)
Historical Stock Chart
From Feb 2024 to Feb 2025